clinical trial · NCT00732368
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)
Organon and Co·phase3·completed·n = 98
Perennial Allergic RhinitisMometasone furoate
brief summary
This study examined the safety and effectiveness of long-term administration of mometasone nasal spray in patients with perennial allergic rhinitis. Patients received mometasone for 12 weeks plus an additional 12 weeks if patient agreed to continue. Dose of mometasone could be decreased or increased during the study based on patient's response.
started
May 1, 2005
primary completion
Jan 1, 2006
completion
Jan 1, 2006
last updated
Aug 15, 2024
official title
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol